Please enable Javascript
Leah Lawrence
Leah Lawrence is a freelance health writer and editor based in Delaware.
Articles by Leah Lawrence
Bispecific Antibodies: New Options
Leah Lawrence
Print
|
January 13, 2023
With more bispecific antibodies in development for hematologic malignancies, physicians must determine how best use them.
Read More
Clinicians Tackle the Challenges of MCL
Leah Lawrence
Print
|
December 22, 2022
Experts discuss areas of progress and where more work is needed to establish a standard of care in mantle cell lymphoma.
Read More
ALL Prognosis in Elderly Patients Has Shown Some Improvement
Leah Lawrence
Meeting News
|
December 20, 2022
There has been an improvement in the prognosis of older patients diagnosed with acute lymphoblastic leukemia.
Read More
Study Examines Resistance to Venetoclax Plus Gilteritinib in R/R AML
Leah Lawrence
Acute Myeloid Leukemia
|
December 19, 2022
Researchers have identified possible resistance mechanisms to gilteritinib plus venetoclax in patients with R/R AML.
Read More
MRD Status Linked with Outcomes in Venetoclax-Treated NPM1-Mutated AML
Leah Lawrence
Acute Myeloid Leukemia
|
December 19, 2022
Molecular MRD was strongly prognostic in patients with NPM1-mutated AML who received venetoclax-based non-intensive therapy.
Read More
MRD Profiling Study Reveals Transcriptional Divergence After Transplant for Myeloma
Leah Lawrence
Myeloma
|
December 10, 2022
Use of drugs with alternative modes of action may be needed to overcome persistent MRD positivity in myeloma.
Read More
Lymphoma Survivors at Increased Risk for Secondary Primary Malignancies
Leah Lawrence
Meeting News
|
December 10, 2022
Survivors of lymphoma are at risk for the development of a second primary malignancy, including new lymphomas.
Read More
Bispecific Antibody Odronextamab Step-Up Regimen Promising in R/R Follicular Lymphoma
Leah Lawrence
Meeting News
|
December 10, 2022
The bispecific antibody odronextamab had “compelling” efficacy in patients with relapsed or refractory follicular ...
Read More
Real-World Selinexor Response Shows Moderate Efficacy
Leah Lawrence
Myeloma
|
December 10, 2022
Selinexor combinations had moderate efficacy in real-world patients with relapsed or refractory multiple myeloma.
Read More
Genome Transcriptome Analysis Reveals More About Hairy Cell Leukemia
Leah Lawrence
Meeting News
|
December 10, 2022
A whole-genome transcriptome sequencing study of hairy cell leukemia revealed a high degree of genomic complexity.
Read More